Posts by Magali Bischof

This year, HUG have implemented Watson for Genomics: the search engine based on tumour genetic information   Watson for Genomics is now used by teams at HUG to support cancer treatment. IBM’s solution facilitates scientific publications’ review based on each tumour’s genetic information. Bringing research time down to 15 minutes, from the former 160 hours…

Abionic and Genentech have signed an agreement to develop and provide rapid Point-of-Care tests for Asthma in the US   On 5 September 2019, Abionic, the developer of proprietary disruptive nanotechnology based rapid diagnostic solutions, and Genentech, a member of the Roche Group, announced a strategic agreement to develop and provide an In Vitro Diagnostic (IVD)…

A minuscule needle synonymous of hope for 16 million patients   FEMTOprint has developed, in partnership with the EPFL and the Jules-Gonin Hospital, a small glass needle which could revolutionize the ophthalmology industry. The 6 centimeter long and 2 millimeter wide needle was highlighted during the high precision meeting (EPHJ-EPMT-SMT) which took place in Geneva in…

HUG‘s Experimental Cell Therapy Lab has developed a stem cell based magical healing sponge   The bioabsorbable sponge has proven to be very promising following the first tests in the lab. The bandage encourages activity, survival and proliferation of cells which in turn fosters vascularisation and healing without being rejected by the patient.   Read…

CHUV Professor Solange Peters & team were granted this year’s GO2 Foundation prize   This year’s Bonnie J. Addario prize rewarded the CHUV Professor & her team for their continuous commitment to the fight against lung cancer and especially their research on biomarkers, patient care access improvement and their work in promoting women in oncology.…

Pharma products take first place on the Swiss export board   The high demande from international markets drives Swiss pharma products to represent 50% of total exports. The industry remains ahead as a result of the continuous implementation of high level innovation. 2019’s second quarter has seen Swiss foreign trade grow by 1,4% according to results…

Professor Cem Gabay has been appointed as the new Dean of the Faculty of Medicine (UNIGE) and Head of the Teaching and Research Department at HUG Professor Cem Gabay takes on his new roles as of 15 July 2019. The Faculty of Medicine counts 2’800 students and 1’800 staff. Every year, 150 new doctors and…

Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform   Boehringer Ingelheim announced on 15 July 2019 the acquisition of UNIGE’s spin-off, AMAL Therapeutics. This move will enable the family-owned pharmaceutical company to “develop new therapies by combining assets from its cancer immunology portfolio with AMAL’s proprietary KISIMA immunization…

Introducing the SBRA “smart bra” project   The SBra project aims to develop an intelligent bra, equipped with sensors, capable of effectively detecting breast cancer early, comfortably and without risk to health. The device would be intended primarily for women considered to be at high risk, not those who are scheduled for a routine screening…

Troy Cox joins SOPHiA GENETICS as the company expands its decentralized approach to Data-Driven Medicine to foster a sustainable and inclusive healthcare system.   Lausanne, SWITZERLAND, July 2, 2019: SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Troy Cox joined its Board of Directors, effective immediately. Mr. Cox, who previously held the position of…